---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-008947"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2024-03-06T23:59:59+00:00"
generated_at: "2026-06-05T02:28:09.279345+00:00"
event_type: "dividend"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# TRxADE Health declares $8 special dividend from asset sale proceeds

## Summary
- Special cash dividend of $8.00 per share declared; payable March 22, 2024 to holders of record March 18, 2024.
- Dividend funded by proceeds from sale of web-based market platform assets (previously announced).
- Company sold subsidiary Superlatus Inc. for $1 to Superlatus Foods Inc. on March 5, 2024.
- Trxade subsidiary agreed to invest up to $5M in Lafayette Energy for convertible preferred stock; second tranche contingent on drilling success.

## SEC filing metadata
- accession: 0001493152-24-008947
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2024-03-06T23:59:59+00:00
- event_type: dividend
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 8.01, 1.01, 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-008947
- JSON: https://secwatch.observer/filing/0001493152-24-008947.json
- Plain text: https://secwatch.observer/filing/0001493152-24-008947.txt

## Key facts
- M&A Transactions
  Scienture Holdings, Inc. completed a disposition involving Superlatus Foods Inc. for $1.00 (closed 2024-03-05).
  - Action: disposition
  - Counterparty: Superlatus Foods Inc.
  - Consideration: $1.00
  - Closing: 2024-03-05
  source text: arch 5, 2024, the Company entered in a Stock Purchase Agreement (“SPA”) with Superlatus Foods Inc. (the “Buyer”). Pursuant to the SPA, the Company sold all of the issued and outstanding stock (the “Stock”) of Superlatus Inc., a Delaware
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm
- Material Agreements
  Scienture Holdings, Inc. entered into Subscription Agreement with Lafayette Energy Corp. valued at up to $5.0 million (effective 2024-02-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Lafayette Energy Corp.
  - Value: up to $5.0 million
  - Effective: 2024-02-29
  source text: On February 29, 2024, the Company’s wholly owned subsidiary Trxade, Inc. entered into a Subscription Agreement (the “Subscription Agreement”) with Lafayette Energy Corp., a Delaware corporation (“Lafayette”). Pursuant to the Subscription Agreement, Trxade, Inc. will, in two equal tranches, invest a total of up to $5.0 million in Lafayette in exchange for up to 2,000,000 shares of Lafayette’s newly created Series A Convertible Preferred Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm
- Material Agreements
  Scienture Holdings, Inc. entered into Stock Purchase Agreement with Superlatus Foods Inc. valued at $1.00 (effective 2024-03-05).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Superlatus Foods Inc.
  - Value: $1.00
  - Effective: 2024-03-05
  source text: On March 5, 2024, the Company entered in a Stock Purchase Agreement (“SPA”) with Superlatus Foods Inc. (the “Buyer”). Pursuant to the SPA, the Company sold all of the issued and outstanding stock (the “Stock”) of Superlatus Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Superlatus”), to the Buyer. The purchase price for the Stock was $1.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224008947/0001493152-24-008947-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.